![]() "We look forward to expanding our offering to provide life science and clinical diagnostics customers with solutions for a wide range of nucleic acid detection applications," Schwartz said.ĭroplet-based PCR from both Bio-Rad and RainDance has been developed for oncology and liquid biopsy applications, viral load monitoring, as well as copy number variation and mosaicism research.īio-Rad announced last week the launch of a single-cell sequencing system co-developed with Illumina. The RainDance intellectual property portfolio will extend Bio-Rad's reach into next-generation sequencing applications and strengthen its position in the area of droplet digital PCR, Bio-Rad CEO Norman Schwartz said in a statement. The RainDance system partitions samples into some 10 million droplets, which is purportedly 500 times greater than the number generated by the Bio-Rad systems. RainDance's systems include RainDrop Digital PCR, ThunderStorm, and ThunderBolts Next-Generation Sequencing Enrichment. The acquisition is expected to close during the first quarter of 2017. NEW YORK (GenomeWeb) – Bio-Rad Laboratories announced today that it has agreed to acquire rival droplet-based PCR systems manufacturer RainDance Technologies for an undisclosed amount. This article has been updated from a previous version to correct the number of droplets generated by the RainDance digital PCR system.
0 Comments
Leave a Reply. |